简介：
Overview
This protocol details the stable plating of dorsal-ventral fused assembloids on multi-electrode arrays (MEAs) to model epilepsy in vitro. It addresses the challenges in measuring electrophysiological activity and understanding the pathological mechanisms of genetic epilepsies using human stem cell-derived brain organoids.
Key Study Components
Area of Science
- Neuroscience
- Epilepsy research
- Neurodevelopment
Background
- Gene discoveries have identified numerous genes associated with epilepsy.
- Pathogenic mechanisms remain underexplored despite advances in modeling.
- Human stem cells and brain organoids have emerged as models for studying genetic epilepsies.
- Measuring neuronal activity in organoids is limited compared to intact animal models.
Purpose of Study
- To establish a protocol for stable plating of assembloids on MEAs.
- To investigate the electrophysiological differences observed in the in vitro models.
- To evaluate the responses to drug treatments in modeling genetic epilepsies.
Methods Used
- Utilization of multi-electrode arrays (MEAs) for electrophysiological recordings.
- Modeling with dorsal-ventral fused assembloids derived from human stem cells.
- Critical steps include MEA surface pre-treatment, well preparation, and assembloid placement.
- Observation of neuronal maturation over time with network activity assessments.
Main Results
- Increased network bursting duration was observed as neurons matured.
- Cellular and network activity changes were monitored over time, ultimately fading by day 125.
- Assessing drug responses may help uncover pathological mechanisms of epilepsy.
Conclusions
- This study provides a robust method for modeling epilepsy in vitro using assembloids on MEAs.
- The findings enable detailed investigations into the pathology and treatment responses of genetic epilepsies.
- Insights gained may enhance understanding of neural mechanisms associated with epilepsy.
What are the advantages of using assembloids on MEAs?
Assembloids allow for more complex modeling of brain structures compared to simple organoids. MEAs facilitate simultaneous recording of electrophysiological activity from multiple sites, enhancing experimental data collection.
How is the biological model of assembloids implemented?
Dorsal-ventral fused assembloids are generated from fate-specific brain organoids. This model enables the study of genetic influences on epilepsy within a controlled environment.
What types of data can be obtained from this method?
Important data includes electrophysiological activity such as network bursting patterns, responses to pharmacological treatments, and maturation timelines of neuronal networks.
How can this protocol be adapted for other studies?
The protocol can be modified by changing the types of assembloids or conditions to study different neurological conditions or treatments and by utilizing alternative drugs to assess varying responses.
Are there any limitations to this method?
A limitation is that brain organoids do not replicate all seizure dynamics of intact animals. Also, the complexity of assembloids may introduce variability in results.
繁體中文
